These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21372510)

  • 21. Cryopyrin activates the inflammasome in response to toxins and ATP.
    Mariathasan S; Weiss DS; Newton K; McBride J; O'Rourke K; Roose-Girma M; Lee WP; Weinrauch Y; Monack DM; Dixit VM
    Nature; 2006 Mar; 440(7081):228-32. PubMed ID: 16407890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.
    Kanneganti TD; Ozören N; Body-Malapel M; Amer A; Park JH; Franchi L; Whitfield J; Barchet W; Colonna M; Vandenabeele P; Bertin J; Coyle A; Grant EP; Akira S; Núñez G
    Nature; 2006 Mar; 440(7081):233-6. PubMed ID: 16407888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms regulating NLRP3 inflammasome activation.
    Jo EK; Kim JK; Shin DM; Sasakawa C
    Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.
    Agostini L; Martinon F; Burns K; McDermott MF; Hawkins PN; Tschopp J
    Immunity; 2004 Mar; 20(3):319-25. PubMed ID: 15030775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.
    Satoh T; Otsuka A; Contassot E; French LE
    Immunotherapy; 2015; 7(3):243-54. PubMed ID: 25804477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammasomes and dermatology.
    Sá DC; Festa C
    An Bras Dermatol; 2016; 91(5):566-578. PubMed ID: 27828627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammasomes: Key Mediators of Lung Immunity.
    Howrylak JA; Nakahira K
    Annu Rev Physiol; 2017 Feb; 79():471-494. PubMed ID: 28192059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammasomes and its importance in viral infections.
    Shrivastava G; León-Juárez M; García-Cordero J; Meza-Sánchez DE; Cedillo-Barrón L
    Immunol Res; 2016 Dec; 64(5-6):1101-1117. PubMed ID: 27699580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
    Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
    Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammasomes in human diseases].
    Jamilloux Y; Sève P; Henry T
    Rev Med Interne; 2014 Nov; 35(11):730-41. PubMed ID: 24907108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.
    Deuteraiou K; Kitas G; Garyfallos A; Dimitroulas T
    Rheumatol Int; 2018 Aug; 38(8):1345-1354. PubMed ID: 29869008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammasomes: guardians of cytosolic sanctity.
    Lamkanfi M; Dixit VM
    Immunol Rev; 2009 Jan; 227(1):95-105. PubMed ID: 19120479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain of function mutation and inflammasome driven diseases in human and mouse models.
    Cordero MD; Alcocer-Gómez E; Ryffel B
    J Autoimmun; 2018 Jul; 91():13-22. PubMed ID: 29610014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NLRP3 inflammasome in kidney disease and autoimmunity.
    Hutton HL; Ooi JD; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COPs and POPs Patrol Inflammasome Activation.
    Indramohan M; Stehlik C; Dorfleutner A
    J Mol Biol; 2018 Jan; 430(2):153-173. PubMed ID: 29024695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and Clinical Examination of Autoinflammatory Syndrome].
    Ida H
    Rinsho Byori; 2015 May; 63(5):598-604. PubMed ID: 26524899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders.
    Cantarini L; Lopalco G; Cattalini M; Vitale A; Galeazzi M; Rigante D
    Isr Med Assoc J; 2015 Feb; 17(2):93-7. PubMed ID: 26223084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.